Trial Profile
A Pilot Study on the Safety and Efficacy of Mavoglurant in Alcohol Drinking
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2023
Price :
$35
*
At a glance
- Drugs Mavoglurant (Primary)
- Indications Alcoholism
- Focus Adverse reactions
- 10 Nov 2023 Status changed from recruiting to completed.
- 26 Jun 2023 Planned primary completion date changed from 31 Jul 2023 to 31 Aug 2023.
- 21 Dec 2022 Planned End Date changed from 31 May 2023 to 31 Aug 2023.